Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy.
Carles Diez-LópezJoel Salazar-MendiguchíaElena García-RomeroLara FuentesJosep LupónAntoni Bayés-GenisNicolás ManitoMarta de AntonioPedro Moliner BorjaElisabet ZamoraPablo Catalá-RuizMiguel Caínzos-AchiricaJosep Comín ColetJosé González-CostelloPublished in: Journal of cardiovascular development and disease (2022)
In patients with NIDCM, LVRR was frequent and was associated with improved prognosis. Major clinical predictors of LVRR were alcoholic cardiomyopathy, absence of LBBB, shorter HF duration, and lower baseline LVEF and NT-proBNP levels. Our study advocates for clinical phenotyping of non-ischaemic dilated cardiomyopathy and intense gold-standard treatment optimization of patients according to current guidelines and recommendations in specialized HF units.
Keyphrases
- left ventricular
- end stage renal disease
- heart failure
- ejection fraction
- chronic kidney disease
- newly diagnosed
- high throughput
- ischemia reperfusion injury
- liver injury
- peritoneal dialysis
- oxidative stress
- mitral valve
- atrial fibrillation
- aortic stenosis
- transcatheter aortic valve replacement
- single cell
- drug induced
- patient reported outcomes
- patient reported